Quanterix - Company & Market Research Reports

Home /
Companies /
Quanterix

Quanterix Corporation develops ultra-sensitive detection systems for use in research and in-vitro diagnostics. The company offers automated immunoassay technology for detection and quantification of biomarkers in in-vitro and companion diagnostics and blood screening. Its products are used in life science, oncology, and neurology research in the United States. Quanterix Corporation was formerly known as Digital Genomics Inc. and changed its name to Quanterix Corporation in August 2007. The company is based in Lexington, Massachusetts.

REFINE BY

KEYWORD

Multiplex Assays Market by Type (Protein [Bead, Planar], Nucleic Acid, Cell) Technology (Flow Cytometry, PCR, Immunoassay) Application (R&D, Diagnosis (Oncology, Cardiovascular, Infectious, Autoimmune Diseases) Product, End User - Global Forecast to 2030

 Report
August 2023
262 Pages
Global

From

€2866EUR$2,923USD£2,388GBP

€4094EUR$4,175USD£3,411GBP

Proteomic Biomarker Analytics Market Forecasts by Application, Technology, Product and Place, with Executive and Consultant Guides

 Report
November 2024
303 Pages
Global

From

€6859EUR$6,995USD£5,716GBP

Companion Diagnostics Development Services Market: Distribution by Type of Service Offered, Analytical Technique Used, Therapeutic Areas and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
March 2022
405 Pages
Global

From

€4706EUR$4,799USD£3,921GBP

Neurological Biomarkers for Alzheimer`S and Parkinson`S Diseases - Global Strategic Business Report

 Report
November 2024
196 Pages
Global

From

€4854EUR$4,950USD£4,045GBP

Neurological Biomarkers Market Size, Share & Trends Analysis Report by Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism), Type, End-use, Region, and Segment Forecasts, 2024-2030

 Report
December 2023
120 Pages
Global

From

€5835EUR$5,950USD£4,862GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Immunoassay for Neurological Biomarkers Market Size, Share & Trends Analysis Report By Product, By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis), By Application, By Region, And Segment Forecasts, 2023 - 2030

 Report
March 2023
134 Pages
Global

From

€5835EUR$5,950USD£4,862GBP

Neurological Biomarkers Market by Type, Application, End-user - Global Forecast 2025-2030

 Report
October 2024
186 Pages
Global

From

€3476EUR$3,545USD£2,897GBP

€3863EUR$3,939USD£3,219GBP

Neurological Biomarkers Market 2024-2028

 Report
February 2024
175 Pages
Global

From

€2451EUR$2,500USD£2,043GBP

Neurological Biomarkers Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Neurological Biomarkers Market By Type, By Application: Global Opportunity Analysis and Industry Forecast, 2021-2031

 Report
September 2022
141 Pages
Global

From

€3501EUR$3,570USD£2,917GBP

Central Nervous System (CNS) Biomarkers: Technologies and Global Markets

 Report
April 2023
135 Pages
Global

From

€2451EUR$2,500USD£2,043GBP

PD-L1 Biomarker Testing Market (2023 Edition): Analysis By Cancer Type (NSCLC, Kidney Cancer, Melanoma, Head and Neck, Bladder Cancer, Others), Assay Kit Type, End Use, By Region, By Country: Market Insights and Forecast (2019-2029)

 Report
September 2023
270 Pages
Global

From

€2402EUR$2,450USD£2,002GBP

Neurological Biomarkers Market Size, Share & Industry Trends Analysis Report by Type (Proteomic, Genomic, Metabolomic), Application (Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis), Regional Outlook and Forecast, 2022-2028

 Report
October 2022
163 Pages
Global

From

€3530EUR$3,600USD£2,942GBP

North America Neurological Biomarkers Market Size, Share & Industry Trends Analysis Report by Type (Proteomic, Genomic, Metabolomic), Application (Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis), Country and Growth Forecast, 2022-2028

 Report
October 2022
67 Pages
North America

From

€1471EUR$1,500USD£1,226GBP

LAMEA Neurological Biomarkers Market Size, Share & Industry Trends Analysis Report by Type (Proteomic, Genomic, Metabolomic), Application (Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis), Country and Growth Forecast, 2022-2028

 Report
October 2022
75 Pages
Middle East, Africa

From

€1471EUR$1,500USD£1,226GBP

Europe Neurological Biomarkers Market Size, Share & Industry Trends Analysis Report by Type (Proteomic, Genomic, Metabolomic), Application (Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis), Country and Growth Forecast, 2022-2028

 Report
October 2022
75 Pages
Europe

From

€1471EUR$1,500USD£1,226GBP

Asia Pacific Neurological Biomarkers Market Size, Share & Industry Trends Analysis Report by Type (Proteomic, Genomic, Metabolomic), Application (Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis), Country and Growth Forecast, 2022-2028

 Report
October 2022
75 Pages
Asia Pacific

From

€1471EUR$1,500USD£1,226GBP

Central Nervous System (CNS) Biomarkers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

 Report
August 2023
117 Pages
Global

From

€4413EUR$4,500USD£3,677GBP

Central Nervous System Biomarkers Market by Biomarker Type, by Application, by End-User, and By Region

 Report
March 2024
200 Pages
Global

From

€4069EUR$4,150USD£3,391GBP

Biomarkers: Technologies and Global Markets 2021

 Report
March 2021
216 Pages
Global

From

€1348EUR$1,375USD£1,123GBP

€2697EUR$2,750USD£2,247GBP

48 Results (Page 1 of 3)
- 1
- 2
- 3

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.